WCM Investment Management
KRTX

WCM Investment Management’s Karuna Therapeutics, Inc. Common Stock KRTX Stock Holding History

WCM Investment Management’s Portfolio KRTX Stock Details KRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-37,686
Closed -$11.9M – 265
2023
Q4 		$11.9M Buy
37,686
+18,146
+93% +$3.53M 0.03% 139
2023
Q3 		$3.3M Buy
19,540
+347
+2% +$65.2K 0.01% 166
2023
Q2 		$4.16M Buy
+19,193
New +$4.11M 0.01% 164

Other funds holding KRTX

IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
S
Sachetta Lynnfield, Massachusetts $206M AUM 26.19% 1-Year Est. Return

WCM Investment Management's KRTX Position: Q1 2024 in Review

WCM Investment Management sold out of Karuna Therapeutics, Inc. Common Stock (KRTX) in Q1 2024, closing a stake of 37,686 shares — an estimated $11.9M sold.

WCM Investment Management first reported a position in KRTX in Q2 2023 and held it in 3 quarters. The position peaked at $11.9M in Q4 2023. 2 funds tracked by Wall St. Rank hold KRTX as of Q1 2024.

  • WCM Investment Management reported no remaining Karuna Therapeutics, Inc. Common Stock position as of Q1 2024 after selling out during the quarter.
  • WCM Investment Management sold 37,686 Karuna Therapeutics, Inc. Common Stock shares in Q1 2024, an estimated $11.9M.
  • WCM Investment Management first reported a position in Karuna Therapeutics, Inc. Common Stock in Q2 2023 and held it in 3 quarters.
  • WCM Investment Management's Karuna Therapeutics, Inc. Common Stock position peaked at $11.9M in Q4 2023.
  • 2 funds tracked by Wall St. Rank held Karuna Therapeutics, Inc. Common Stock as of Q1 2024.

Based on WCM Investment Management's 13F filing for Q1 2024, filed 25 Apr 2024.